These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

148 related items for PubMed ID: 3072177

  • 1. Pathophysiology of diastolic hypertension.
    Laragh JH.
    Health Psychol; 1988; 7 Suppl():15-31. PubMed ID: 3072177
    [Abstract] [Full Text] [Related]

  • 2. Recognizing and treating two types of long-term vasoconstriction in hypertension.
    Laragh JH, Resnick LM.
    Kidney Int Suppl; 1988 Sep; 25():S162-74. PubMed ID: 3054233
    [Abstract] [Full Text] [Related]

  • 3. Two forms of vasoconstriction in systemic hypertension.
    Laragh JH.
    Am J Cardiol; 1987 Oct 30; 60(12):82G-93G. PubMed ID: 3314453
    [Abstract] [Full Text] [Related]

  • 4. Issues, goals, and guidelines in selecting first-line drug therapy for hypertension.
    Laragh JH.
    Hypertension; 1989 May 30; 13(5 Suppl):I103-12. PubMed ID: 2490815
    [Abstract] [Full Text] [Related]

  • 5. Clinical parameters of concern in the pathology and treatment of hypertension.
    Laragh JH.
    J Clin Hypertens; 1986 Sep 30; 2(3 Suppl):1S-11S. PubMed ID: 2947978
    [Abstract] [Full Text] [Related]

  • 6. The renin system and new understanding of the complications of hypertension and their treatment.
    Laragh JH.
    Arzneimittelforschung; 1993 Feb 30; 43(2A):247-54. PubMed ID: 8498972
    [Abstract] [Full Text] [Related]

  • 7. Converting enzyme inhibition to identify and treat renin-mediated or sodium-volume related forms of increased peripheral resistance in hypertension and in congestive heart failure.
    Cody RJ, Laragh JH, Atlas SA, Case DB.
    J Hypertens Suppl; 1983 Oct 30; 1(1):77-84. PubMed ID: 6085835
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Lewis K. Dahl Memorial Lecture. The renin system and four lines fo hypertension research. Nephron heterogeneity, the calcium connection, the prorenin vasodilator limb, and plasma renin and heart attack.
    Laragh JH.
    Hypertension; 1992 Sep 30; 20(3):267-79. PubMed ID: 1516945
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Renin, sodium, and vasodepressor response to saralasin in renovascular and essential hypertension.
    Marks LS, Maxwell MH, Kaufman JJ.
    Ann Intern Med; 1977 Aug 30; 87(2):176-82. PubMed ID: 889198
    [Abstract] [Full Text] [Related]

  • 16. Renal effects of beta blockade in essential hypertension.
    de Leeuw PW, Birkenhäger WH.
    Eur Heart J; 1983 Jul 30; 4 Suppl D():13-7. PubMed ID: 6137372
    [Abstract] [Full Text] [Related]

  • 17. Endothelin A receptor blocker atrasentan lowers blood pressure by the reduction of nifedipine-sensitive calcium influx in Ren-2 transgenic rats fed a high-salt diet.
    Vaněčková I, Dobešová Z, Kuneš J, Vernerová Z, Zicha J.
    J Hypertens; 2015 Jan 30; 33(1):161-9. PubMed ID: 25255392
    [Abstract] [Full Text] [Related]

  • 18. Hypotensive effects of sodium volume depletion and 1-sar-8-ala-angiotensin II in relation to plasma renin in hypertensive patients.
    Fagard R, Amery A, Lijnen P, Reybrouck T.
    Eur J Clin Pharmacol; 1977 Aug 17; 12(1):1-5. PubMed ID: 902672
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.